{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:51Z","timestamp":1707524091801},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,30]]},"DOI":"10.7759\/cureus.10143","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T04:38:59Z","timestamp":1598848739000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy"],"prefix":"10.7759","author":[{"given":"Koichi","family":"Narita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux240","article-title":"Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE)","volume":"19","author":"Lip GYH","year":"2017","unstructured":"Lip GYH, Collet JP, de Caterina R, et al.; ESC Scientific Document Group. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE). Europace. 2017, 19:1757-1758. 10.1093\/europace\/eux240","journal-title":"Europace"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-132. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000170642.39876.f2","article-title":"Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas","volume":"36","author":"Hart RG","year":"2005","unstructured":"Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005, 36:1588-1593. 10.1161\/01.STR.0000170642.39876.f2","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.504993","article-title":"Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study","volume":"39","author":"Toyoda K","year":"2008","unstructured":"Toyoda K, Yasaka M, Iwade K, et al.; Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke. 2008, 39:1740-1745. 10.1161\/STROKEAHA.107.504993","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2990.2010.01137.x","article-title":"Review: sporadic cerebral amyloid angiopathy","volume":"37","author":"Attems J","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2011, 37:75-93.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan A","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011, 70:871-880. 10.1002\/ana.22516","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill JC III","year":"2015","unstructured":"Hemphill JC III, Greenberg SM, Anderson CS, et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015, 46:2032-2060. 10.1161\/STR.0000000000000069","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-992. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.1623","article-title":"The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2- VASc scores in anticoagulated patients with atrial fibrillation","volume":"62","author":"Rold\u00e1n V","year":"2013","unstructured":"Rold\u00e1n V, Mar\u00edn F, Manzano-Fern\u00e1ndez S, et al.. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2- VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013, 62:2199-2204. 10.1016\/j.jacc.2013.08.1623","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.724","article-title":"Cerebral amyloid angiopathy diagnosis, clinical implications, and management strategies in atrial fibrillation","volume":"70","author":"DeSimone CV","year":"2017","unstructured":"DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DR Jr. Cerebral amyloid angiopathy diagnosis, clinical implications, and management strategies in atrial fibrillation. J Am Coll Cardiol. 2017, 70:1173-1182. 10.1016\/j.jacc.2017.07.724","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.08.024","article-title":"Deposition of amyloid b in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy","volume":"1862","author":"Keable A","year":"2016","unstructured":"Keable A, Fenna K, Yuen HM, et al.. Deposition of amyloid b in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016, 1862:1037-1046. 10.1016\/j.bbadis.2015.08.024","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826043a9","article-title":"Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy","volume":"79","author":"Gurol ME","year":"2012","unstructured":"Gurol ME, Dierksen G, Betensky R, et al.. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology. 2012, 79:320-326. 10.1212\/WNL.0b013e31826043a9","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0091-7","article-title":"The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets","volume":"6","author":"Qi XM","year":"2017","unstructured":"Qi XM, Ma JF. The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets. Transl Neurodegener. 2017, 6:22. 10.1186\/s40035-017-0091-7","journal-title":"Transl Neurodegener"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.523159","article-title":"Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?","volume":"39","author":"Eckman MH","year":"2008","unstructured":"Eckman MH, Wong LK, Soo YO, Lam W, Yang SR, Greenberg SM, Rosand J. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?. Stroke. 2008, 39:3308-3315. 10.1161\/STROKEAHA.108.523159","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414930112","article-title":"Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice","volume":"112","author":"Han BH","year":"2015","unstructured":"Han BH, Zhou ML, Johnson AW, et al.. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc Natl Acad Sci USA. 2015, 112:E881-E890. 10.1073\/pnas.1414930112","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174140","article-title":"Edoxaban exerts antioxidant effects through FXa inhibition and direct radical-scavenging activity","volume":"20","author":"Narita Y","year":"2019","unstructured":"Narita Y, Hamamura K, Kashiyama M, et al.. Edoxaban exerts antioxidant effects through FXa inhibition and direct radical-scavenging activity. Int J Mol Sci. 2019, 20:4140. 10.3390\/ijms20174140","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study","volume":"178","author":"O'Donnell MJ","year":"2016","unstructured":"O'Donnell MJ, Eikelboom JW, Yusuf S, et al.. Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. Am Heart J. 2016, 178:145-150. 10.1016\/j.ahj.2016.03.019","journal-title":"Am Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1052-1","article-title":"The clinical dilemma of anticoagulation use in patients with cerebral amyloid angiopathy and atrial fibrillation","volume":"20","author":"Cannistraro RJ","year":"2018","unstructured":"Cannistraro RJ, Meschia JF. The clinical dilemma of anticoagulation use in patients with cerebral amyloid angiopathy and atrial fibrillation. Curr Cardiol Rep. 2018, 20:106. 10.1007\/s11886-018-1052-1","journal-title":"Curr Cardiol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.650614","article-title":"Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial","volume":"43","author":"Hart RG","year":"2012","unstructured":"Hart RG, Diener HC, Yang S, et al.. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012, 43:1511-1517. 10.1161\/STROKEAHA.112.650614","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078259","article-title":"Cerebral hemorrhage after passive anti-Abeta immunotherapy","volume":"298","author":"Pfeifer M","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, et al.. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science. 2002, 298:1379. 10.1126\/science.1078259","journal-title":"Science"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39411-efficacy-and-safety-of-direct-oral-anticoagulant-for-treatment-of-atrial-fibrillation-in-cerebral-amyloid-angiopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:37Z","timestamp":1707506497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39411-efficacy-and-safety-of-direct-oral-anticoagulant-for-treatment-of-atrial-fibrillation-in-cerebral-amyloid-angiopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.10143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,30]]}}}